Locke Lord advised Imugene Ltd. on the transaction. Precision BioSciences, Inc. (Nasdaq: DTIL) announced it has completed a transaction with Imugene Limited (ASX: IMU) for global rights...
You must be a Standard 1 Year member to access this content.
Ropes & Gray, working alongside Walkers, represented Pfizer, while Skadden advised Centerview Partners, the financial advisor to Biohaven Pharmaceutical on the deal. S&C, Maples and Calder...
You must be a Standard 1 Year member to access this content.
Gleiss Lutz advised Integer on the deal while Locke Lord represented Oscor. The US company Integer, a leading medical device outsource manufacturer, announced its USD 220...
You must be a Standard 1 Year member to access this content.
Locke Lord LLP advised Shanghai Haohai Biological Technology Co. on the deal. Shanghai Haohai Biological Technology Co., Ltd., a public company traded on the Hong Kong...
You must be a Standard 1 Year member to access this content.
